Federal (United States)
United StatesFDA approved labeling changes removing the boxed warning on menopausal hormone therapy (February 2026).
On 12 February 2026 the FDA approved labeling changes to six menopausal hormone therapy products, removing the cardiovascular disease, breast cancer and probable dementia risk statements from the boxed warning that had sat there since the WHI scare. It does not change how MHT is prescribed, and your own history still drives the decision, but it changes the conversation. Bone density tests still aren't covered under Medicare until age 65, despite the fastest bone loss happening in the first five years post-menopause.
- Workplace
- Not yet
- Hormone coverage
- Partial
- Provider education
- Not yet
- Public awareness
- Partial
FDA press announcement, February 2026 →
Rhode Island
United StatesWorkplace accommodations law passed.
Rhode Island became one of the first US states to put menopause-specific workplace protections on the books — covering reasonable accommodations like temperature control, breaks, and uniform flexibility. Closer to the UK Equality Act model than anything else in US law.
- Workplace
- Yes
- Hormone coverage
- Not yet
- Provider education
- Not yet
- Public awareness
- Partial
Connecticut
United StatesTwo laws passed in 2026: workplace accommodation rights plus a statewide provider toolkit.
SB 353 (Public Act 26-12) explicitly includes menopause-related impairment in Connecticut's workplace accommodation protections, requires employers to notify workers of those rights, and directs the state to publish model workplace policies. HB 5389 (Public Act 26-13) funds an evidence-based provider toolkit for diagnosing and treating perimenopause and menopause, designed with the UConn Health Disparities Institute. Both grew out of the community-led Menopause Equity Initiative, which centred Black women and other marginalized communities from the first listening session.
- Workplace
- Yes
- Hormone coverage
- Partial
- Provider education
- Yes
- Public awareness
- Partial
UConn Today, August 2026 →
New Jersey
United StatesMost comprehensive package in the US.
New Jersey has moved on the widest bundle — insurance coverage requirements, provider education funding, workplace guidance, and awareness programmes — in a single legislative push. Bellwether for other Northeast states.
- Workplace
- Partial
- Hormone coverage
- Yes
- Provider education
- Partial
- Public awareness
- Yes
Pennsylvania
United StatesFour bills in play, including the off-label testosterone fight.
Pennsylvania has four active menopause bills, the most-watched of which would make it easier for clinicians to prescribe testosterone off-label for women — currently a postcode lottery and a major reason the libido conversation stalls at the appointment.
- Workplace
- Partial
- Hormone coverage
- Partial
- Provider education
- Partial
- Public awareness
- Partial
Other US states (26 and counting)
United StatesSomething has passed in 26 states since 2019; 60+ bills introduced in 2026 alone.
Most movement is in workplace accommodations and provider education. Coverage mandates are rarer and harder. Worth checking your specific state legislature page — this is the fastest-moving area of US health law in 2026.
- Workplace
- Partial
- Hormone coverage
- Partial
- Provider education
- Partial
- Public awareness
- Partial
British Columbia
CanadaMHT fully covered under National Pharmacare (Plan NP) since March 2026; complex menopause clinic at BC Women's.
Since March 1, 2026, many MHT products are free for MSP-enrolled BC residents: no medication cost, no dispensing fee, no Special Authority. Before that, PharmaCare listed MHT but most people paid up to an income-based deductible. BC Women's Hospital also runs a Complex Menopause Clinic (referral required) for severe or multi-system cases — virtual and in-person, with Menopause Society-certified clinicians.
- Workplace
- Not yet
- Hormone coverage
- Yes
- Provider education
- Partial
- Public awareness
- Partial
Manitoba
CanadaFree hormone therapy under the Enhanced Pharmacare Program since April 2025.
The first province in Canada to make hormone therapy free at the pharmacy counter. MEPP covers most HRT medications (plus the dispensing fee) for anyone with an active Manitoba Health card who isn't already covered 100% elsewhere.
- Workplace
- Not yet
- Hormone coverage
- Yes
- Provider education
- Not yet
- Public awareness
- Partial
Other Canadian provinces & territories
CanadaMostly private/out-of-pocket; senior and special-support programmes only.
Ontario, Quebec, Alberta, Saskatchewan, the Atlantic provinces and the territories cover MHT through age-restricted or means-tested programmes, not as a universal benefit. Detail and current pricing on our province-by-province page.
- Workplace
- Not yet
- Hormone coverage
- Partial
- Provider education
- Not yet
- Public awareness
- Partial
See: MHT coverage in Canada →
United Kingdom
United KingdomEquality Act 2010 covers menopause via age, sex and disability routes.
There is no menopause-specific UK statute. Menopause is protected indirectly under the Equality Act 2010 via age, sex and (where symptoms are long-term and substantial) disability. NHS prescription charges for HRT were reduced to an annual prepayment certificate in England (April 2023); HRT is free at point of access in Scotland, Wales and Northern Ireland. Employer guidance is voluntary; tribunal case law is the active edge.
- Workplace
- Partial
- Hormone coverage
- Yes
- Provider education
- Partial
- Public awareness
- Yes
